pharmaphorum January 30, 2024
Elon Musk’s Neuralink company has said it has implanted its wireless brain implant device into a human being for the first time, following FDA approval of clinical trials last year.
In a series of updates on X (formerly Twitter), Musk said there had been promising signs of “neuron spike detection” in the individual – suggesting the device had been implanted correctly – and that they were recovering well from the surgical procedure.
The PRIME trial aims to show that the implant can act as a hands-free interface between the brain and electronic devices, controlling them with thoughts alone, with an early application expected to be the treatment of complex neurological conditions, such as paralysis.
Other potential uses previously discussed for...
Today's Sponsors
Today's Sponsor